Long-term Follow-up of Fingolimod Phase II Study Patients

Clinical trial NCT02307838 · COMPLETED

Trial details

NCT number: NCT02307838
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis

Start date: 2014-06-01
Primary completion: 2015-12-01
Enrollment: 177

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.